Poseida Therapeutics, Inc. (PSTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 2.6700 |
| Open | 2.6300 |
| Bid | 2.3900 x 1300 |
| Ask | 2.6600 x 1100 |
| Day's range | 2.3819 - 2.6500 |
| 52-week range | 1.5400 - 8.8200 |
| Volume | |
| Avg. volume | 489,803 |
| Market cap | 252.448M |
| Beta (5Y monthly) | -0.01 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Poseida Therapeutics, Inc. (PSTX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Poseida Therapeutics, Inc. (PSTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
All You Need to Know About Poseida Therapeutics, Inc. (PSTX) Rating Upgrade to Buy
Poseida Therapeutics, Inc. (PSTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Simply Wall St.
Institutional investors may adopt severe steps after Poseida Therapeutics, Inc.'s (NASDAQ:PSTX) latest 13% drop adds to a year losses
Key Insights Significantly high institutional ownership implies Poseida Therapeutics' stock price is sensitive to their...
© 2023 Yahoo. All rights reserved.